Zurich Cantonal Bank
RCUS icon

Zurich Cantonal Bank’s Arcus Biosciences RCUS Stock Holding History

Zurich Cantonal Bank’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
59,021
+7,997
+16% +$198K ﹤0.01% 1190
2026
Q1 		$1.1M Buy
51,024
+14,095
+38% +$304K ﹤0.01% 1376
2025
Q4 		$880K Buy
36,929
+11,708
+46% +$239K ﹤0.01% 1419
2025
Q3 		$343K Sell
25,221
-10,550
-29% -$110K ﹤0.01% 1933
2025
Q2 		$291K Buy
35,771
+23
+0.1% +$196 ﹤0.01% 1974
2025
Q1 		$281K Buy
35,748
+2,524
+8% +$29.3K ﹤0.01% 1922
2024
Q4 		$495K Buy
33,224
+2,443
+8% +$39.9K ﹤0.01% 1634
2024
Q3 		$471K Buy
30,781
+843
+3% +$13.3K ﹤0.01% 1605
2024
Q2 		$456K Sell
29,938
-307
-1% -$4.96K ﹤0.01% 1549
2024
Q1 		$571K Buy
30,245
+11,362
+60% +$196K ﹤0.01% 1379
2023
Q4 		$361K Buy
18,883
+5,151
+38% +$82.3K ﹤0.01% 1719
2023
Q3 		$246K Buy
13,732
+2,289
+20% +$46K ﹤0.01% 1839
2023
Q2 		$232K Buy
11,443
+160
+1% +$3.05K ﹤0.01% 1828
2023
Q1 		$206K Sell
11,283
-111
-1% -$2.12K ﹤0.01% 1839
2022
Q4 		$236K Sell
11,394
-50
-0.4% -$1.38K ﹤0.01% 1731
2022
Q3 		$299K Sell
11,444
-415
-3% -$11K ﹤0.01% 1515
2022
Q2 		$301K Sell
11,859
-451
-4% -$11K ﹤0.01% 1556
2022
Q1 		$389K Sell
12,310
-238
-2% -$7.97K ﹤0.01% 1482
2021
Q4 		$508K Buy
12,548
+44
+0.4% +$1.71K ﹤0.01% 1432
2021
Q3 		$436K Sell
12,504
-180
-1% -$5.6K ﹤0.01% 1394
2021
Q2 		$348K Buy
12,684
+388
+3% +$11.1K ﹤0.01% 1450
2021
Q1 		$345K Buy
12,296
+4,499
+58% +$157K ﹤0.01% 1453
2020
Q4 		$202K Buy
7,797
+4,639
+147% +$112K ﹤0.01% 1839
2020
Q3 		$54K Buy
3,158
+1,714
+119% +$38.3K ﹤0.01% 2236
2020
Q2 		$36K Buy
+1,444
New +$39K ﹤0.01% 2304

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Zurich Cantonal Bank's RCUS Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Arcus Biosciences (RCUS) stake by 16% in Q2 2026, buying an estimated $198K and bringing the position to 59,021 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Zurich Cantonal Bank first reported a position in RCUS in Q2 2020 and has held it in 25 quarters since. 230 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Zurich Cantonal Bank held 59,021 shares of Arcus Biosciences worth $1.82M as of Q2 2026.
  • Zurich Cantonal Bank bought 7,997 Arcus Biosciences shares in Q2 2026, an estimated $198K.
  • Arcus Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1190 holding.
  • Zurich Cantonal Bank first reported a position in Arcus Biosciences in Q2 2020 and has held it in 25 quarters since.
  • 230 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.